Lunai Bioworks Announces 1-for-8 Reverse Stock Split

Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks The latest announcement is out from Lunai Bioworks ( (LNAI) ). Lunai Bioworks, Inc. announced on May 20, 2026, that it will implement a 1-for-8 reverse stock split of its common shares, effective at 12:01 a.m. Eastern Time on May 22, 2026, with trading on the Nasdaq Capital Market to begin on a split-adjusted basis the same day under ticker LNAI and a new CUSIP. The move, approved by shareholders at a May 8, 2026 special meeting and following a prior 1-for-10 reverse split in September 2025, will shrink outstanding shares from about 36.3 million to 4.5 million and is primarily aimed at lifting the share price to restore compliance with Nasdaq’s minimum bid requirement, with proportional adjustments applied to outstanding equity-linked securities and no fractional shares issued. The reverse stock split will consolidate every eight existing shares into one while leaving the par value and authorized share count unchanged, potentially affecting trading liquidity and volatility for investors. Stockholders’ positions will be automatically adjusted through the company’s transfer agent and intermediaries, and the action underscores Lunai Bioworks’ efforts to preserve its Nasdaq listing as it continues developing AI-enabled precision drugs in CNS and oncology markets. More about Lunai Bioworks Lunai Bioworks, Inc. is an AI-driven life sciences company that applies an integrated platform combining clinical data, machine learning and in vivo validation to advance drug discovery and chemical defense. The company focuses on central nervous system diseases and oncology, aiming to develop precision therapeutics that shorten development timelines and improve clinical success rates. Average Trading Volume: 21,785,490 Technical Sentiment Signal: Strong Sell Current Market Cap: $9.38M See more data about LNAI stock on TipRanks’ Stock Analysis page.